A major study demonstrates that semaglutide (Ozempic/Wegovy) delivers significant weight loss in adults over 65, with participants losing over 15% of body weight and improving metabolic health.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Ozempic delivers major weight loss in adults over 65, study finds
Over 15% Of Body Weight % Average weight loss in drug group
65 And Older years Age group studied
Heart And Metabolic Health Improved Health improvements
Many Moved Out Of Obesity Categories Patient outcomes
65+ age group
15% weight loss